UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

SCHEDULE 14A

 

Proxy Statement Pursuant to Section 14(a) of the Securities

Exchange Act of 1934

 

Filed by the registrant ☒ Filed by a Party other than the Registrant ☐

 

Check the appropriate box:

 

  ☐ Preliminary Proxy Statement ☐ Confidential, For Use
  ☐ Definitive Proxy Statement   of the Commission Only
  ☒ Definitive Additional Materials   (as permitted by Rule
  ☐ Soliciting Material under Rule 14a-12   14a-6(e)(2))

 

GT BIOPHARMA, INC.

(Name of Registrant as Specified in Its Charter)

 

 

 

(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)

 

Payment of Filing Fee (Check the appropriate box):

 

☒ No Fee Required
   
☐ Fee paid previously with preliminary materials
   
☐ Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11

 

 

 

 
 

 

 

 

 

 

 

 

GT Biopharma (NASDAQ:GTBP)
Gráfico Histórico do Ativo
De Jan 2025 até Fev 2025 Click aqui para mais gráficos GT Biopharma.
GT Biopharma (NASDAQ:GTBP)
Gráfico Histórico do Ativo
De Fev 2024 até Fev 2025 Click aqui para mais gráficos GT Biopharma.